News

LIFE-GREENAPI is a 3-year initiative aimed at proposing a technological shift in Active Pharmaceutical Ingredients (APIs) production to promote sustainability in the European Pharmaceutical Sector.

Every year on May 24th, World Schizophrenia Awareness Day shines a light on a complex and often misunderstood mental illness that affects over 24 million people globally.

To mark Clinical Trials Day 2025, Angelini Pharma has created an animated video infographic that takes viewers on a journey through the key steps and roles involved in a clinical trial.

In anticipation of European Mental Health Week 2025 we turn to the story of Juan Manuel Fernandez, a professional basketball player who overcame depression and has become an important advocate for mental health awareness.

In an in-depth interview with Executive Forecast, Angelini Pharma CEO Jacopo Andreose discusses the company’s strategic evolution, highlighting priorities in R&D, international growth, and patient engagement.

On Earth Day 2025, the theme "OUR POWER, OUR PLANET" emphasizes the urgent need to triple the production of renewable energy globally by 2030.

Explore insights from six leading epileptologists on the evolution of epilepsy diagnosis and treatment, highlighting innovations and future challenges from the 2024 ILAE Congress.

Epilepsy is one of the most common neurological disorders. Despite its prevalence, widespread misconceptions and social stigma continue to marginalize those living with the condition.

Gender-based violence has a profound impact on women’s mental health, often leading to anxiety, depression, and post-traumatic stress disorder (PTSD).

The United Nations launched this initiative in 2015 to promote gender equality in STEM, an opportunity to support and include women and girls in order for them to receive full and equal access to careers in science.